During the past decade, Northeast Iowa Medical Education Foundation conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northeast Iowa Medical Education Foundation" #1 sponsor was "Northeast Iowa Medical Education Foundation" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Korey Kennelty" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast Iowa Medical Education Foundation" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "University of Iowa" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Northeast Iowa Medical Education Foundation" are "Cardiovascular Disease" (3 trials), "Hypertension" (3 trials), "Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Coronary Syndromes" (1 trials). Many other conditions were trialed in "Northeast Iowa Medical Education Foundation" in a lesser frequency.

Most popular intervention types in "Northeast Iowa Medical Education Foundation" are "Drug" (6 trials), "Other" (3 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "CVRS Intervention" (2 trials), "bococizumab (PF-04950615)" (2 trials), "24 Month PPCM BP" (1 trials) and "9 Month PPCM BP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northeast Iowa Medical Education Foundation" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Northeast Iowa Medical Education Foundation". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Northeast Iowa Medical Education Foundation, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Northeast Iowa Medical Education Foundation, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".